Forbes -
9 May 2014 19:49
With this acquisition, Boston Scientific aims to gain share in the fast growing hysteroscopic (uterus related) surgery market. It could be easier for the company to enter this market with its non-traditional treatment approach now that the commonly-used methods (power morcellators) are coming under fire.
Share this Article
Comment on this Article
Please to comment